Structure Therapeutics Inc. — Director's Dealing 2023

Feb 9, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2023-02-07

Reporting Person: FIL Ltd (See Remark 1)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-07	Ordinary Shares	C	4013678	—	Acquired	4013678	Indirect
2023-02-07	Ordinary Shares	C	620499	—	Acquired	4634177	Indirect
2023-02-07	Ordinary Shares	C	452867	—	Acquired	5087044	Indirect
2023-02-07	Ordinary Shares	C	179242	—	Acquired	5266286	Indirect
2023-02-07	Ordinary Shares	C	71636	—	Acquired	71636	Indirect
2023-02-07	Ordinary Shares	C	10154	—	Acquired	81790	Indirect
2023-02-07	Ordinary Shares	C	7411	—	Acquired	89201	Indirect
2023-02-07	Ordinary Shares	C	494035	—	Acquired	494035	Indirect
2023-02-07	Ordinary Shares	C	624239	—	Acquired	624239	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-07	Series A Convertible Preferred Shares	$	C	4013678	Disposed		Ordinary Shares (4013678)	Indirect
2023-02-07	Series A+ Convertible Preferred Shares	$	C	620499	Disposed		Ordinary Shares (620499)	Indirect
2023-02-07	Series B Convertible Preferred Shares	$	C	452867	Disposed		Ordinary Shares (452867)	Indirect
2023-02-07	Series B-1 Convertible Preferred Shares	$	C	179242	Disposed		Ordinary Shares (179242)	Indirect
2023-02-07	Series A Convertible Preferred Shares	$	C	71636	Disposed		Ordinary Shares (71636)	Indirect
2023-02-07	Series A+ Convertible Preferred Shares	$	C	10154	Disposed		Ordinary Shares (10154)	Indirect
2023-02-07	Series B Convertible Preferred Shares	$	C	7411	Disposed		Ordinary Shares (7411)	Indirect
2023-02-07	Series B-1 Convertible Preferred Shares	$	C	494035	Disposed		Ordinary Shares (494035)	Indirect
2023-02-07	Series A Convertible Preferred Shares	$	C	624239	Disposed		Ordinary Shares (624239)	Indirect

Footnotes

F1: On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares.